Evaluation of the Effects of a Diabetes Disease Management Program on Outpatient Health Care
|
|
- Adam Hodges
- 8 years ago
- Views:
Transcription
1 Evaluation of the Effects of a Diabetes Disease Management Program on Outpatient Health Care Prof. Dr. Herwig Ostermann 1 Dr. Margit Raich 1 Prof. Dr. Harald Stummer 2 Dr. Michael Müller 1,3 1 Division for Health Policy, Administration and Law 2 Division for Organisation and Health Promotions Department of Public Health and HTA University for Health Sciences, Medical Informatics and Technology Eduard Wallnöfer-Zentrum I, 6060 Hall in Tyrol, Austria 3 Unit for Health Management Social Insurance Institution for Business Wiedner Hauptstraße 84-86, 1050 Vienna, Austria 43
2 Context I Diabetes Basics Complex, non-communicable chronic disease Number of people affected worldwide 2010 estimate: 285 million (prevalence 6.4%) 2030 estimate: 438 million (prevalence 7.8%) Regional variances United States: 8%+ European Union: 3-6% Austria: 4% Burden of diabetes Severe complications associated with (unmanaged) diabetes (high-income countries) Most common cause for adult blindness 1/3 of all dialysis patients suffer from diabetes 20 times more at risk of amputations 2-3 times more at risk of cardiovascular diseases (CVD) More frequent utilization of health care services Sources: World Diabetes Foundation, 2010; Lemmens et al., 2011; Pieber, 2008; 44
3 Context II Diabetes Basics (cont d) Treatment of diabetes Chronic disease, lifelong therapy Lifestyle modifications Diabetic diet (type 2) Oral mediations Anti-diabetic medications (type 2) Insulin therapy Usually injected subcutaneously (type 1, type 2) Combined therapy Anti-diabetic medications and insulin (type 2) Sources: Harris et al., 2010; Pieber,
4 Context III The rationale of DMPs Main thrust of disease management Improvement of effectiveness and economic efficiency of health care delivery via Coordinated health care delivery Standardisation of treatment pathways Implementation of treatment guidelines Better outcomes at reasonable or even lower costs DMP target groups Chronic diseases (diabetes, CVD) High patient-involvement Chronic care delivery / long-term treatment Existence of treatment pathways and (evidence-based) guidelines Sources: Lemmens et al, 2001; Federation of Austrian Social Insurance Institutions,
5 Methods I Study population Patient records (outpatient care) of the Social Insurance Institution for Business Part of the Austrian mandatory social insurance system Covers self-employed persons and their relatives 705,607 insured persons (2009) 467,656 mandatorily insured persons / 225,633 relatives 21,299 diabetes patients treated with oral anti-diabetic medication and/or insulin Diabetes type 2 patients administered diabetic diet only not included, as patient records only include prescribed medication 514 patients enrolled in the DMP Data sources Central data warehouse (operated by the Federation of Austrian Social Insurance Institutions) Source: Social Insurance Institution for Business,
6 Methods II Study population (cont d) Demographic characteristics of study population no substantial difference in terms of sex and age other data (income, education) not available overall collective of insurees homogenous in terms of sociodemographic characteristics due to coverage of self-employed persons only 48
7 Methods III The Austrian diabetes DMP Therapie Aktiv Evidence-based treatment pathways International research Guidelines of the Austrian Society for Diabetes Basic characteristics Voluntary participation No financial incentive for participating patients Lump sum payment per patient enrolled for participating physicians Physician training Compulsory participation in certified courses Patient empowerment Quality management Compulsory checklists Standardized reporting Treatment pathways In order to support medical decision making of all physicians involved in treatment process Source: Federation of Austrian Social Insurance Institutions,
8 Methods IV Assessed parameters Pattern of outpatient care service utilization Number of specific services received by each patient in 2009 Overall costs of specific services received by each patient in 2009 Hospitalization Patients hospitalized Days of hospitalization Average costs for outpatient care and medication Costs for hospital care not available in patient records due to central funding of the Austrian DRGs 50
9 Results I Outpatient service utilization Source of data: Data warehouse, own retrieval and analysis 51
10 Results II Outpatient service utilization (cont d) Source of data: Data warehouse, own retrieval and analysis 52
11 Results III Hospitalization Source of data: Date warehouse, own retrieval and analysis 53
12 Results IV Costs for outpatient care and medication Source of data: Data warehouse, own retrieval and analysis 54
13 Discussion I Overall effects Patients enrolled in the program benefit from More evolved pattern of outpatient services Higher amount of specialist services (33 vs. 23) and laboratory services (14 vs. 9) Less non-medical services such as wound care bandaging (14 vs. 42) or transport services (7 vs. 39) Less hospitalization Less share of patients hospitalized (33% vs. 37%) and less days hospitalized (10.7 vs. 17.3) Shift from inpatient to outpatient care DMP patients are expected to cause lower costs No significant difference in costs for outpatient care and medication ( 2,874 p.c. vs. 2,773 p.c.) Costs for hospital services are expected to be lower due to less hospitalization of enrolled patients Accounting for nearly half the days of regular patients (3.5 vs. 6.4) 55
14 Discussion II Limitations Limitations Empirical design No randomization, no baseline measurement Selection bias Personal factors (severity/length of disease, motivation, prognosis, comorbidity) not included Substantial differences in socio-demographic characteristics unlikely due to homogenous collective of insurees More evolved pattern of outpatient care and less hospitalization must not reflect better health outcomes Further research and/or Standardized reporting of health outcomes needed Time of survival not available due to start of DMP in 2007 Sources: Schäfer et al., 2010; Pieber, 2008; Miksch et al.,
15 Outlook Implications for health policy makers Results of the Austrian diabetes disease management program generally in line with international research as well as intended effects of DMPs better health care delivery at reasonable/lower costs BUT: Mechanisms causing these results still unclear due to limitations in design of current research Selection effects in enrolment may account for better results along with mechanisms of DMP Mechanisms of DMP may account for better results Approval procedure for implementation of alternative forms of management of health care delivery advisable In order to safeguard ethical standards as well as sufficient empirical evidence Sources: Schäfer et al., 2010; Miksch et al., 2010; Breyer,
16 Comments? Questions? Remarks? 58
17 Acknowledgements Dr. Thomas Neumann Social Insurance Institution for Business Vienna, Austria Dr. Oskar Staudinger S2-engineering Steyr, Austria 59
The below tables outline the types of health care services as well as delivery settings:
Assuring Quality Health Care Delivery in Asia Introduction Guk-Hee Suh, PhD, MD, 2014-2016 Chair, ISPOR Asia Consortium Health Service Providers (Clinicians) Committee, and Professor of Psychiatry, Hallym
More informationRobert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
More information2014 -- H 8166 S T A T E O F R H O D E I S L A N D
LC000 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO INSURANCE - ACCIDENT AND SICKNESS INSURANCE POLICIES Introduced By: Representatives
More informationRisk Adjustment in the Medicare ACO Shared Savings Program
Risk Adjustment in the Medicare ACO Shared Savings Program Presented by: John Kautter Presented at: AcademyHealth Conference Baltimore, MD June 23-25, 2013 RTI International is a trade name of Research
More informationDESCRIPTIONS OF HEALTH CARE SYSTEMS: GERMANY AND THE NETHERLANDS
DESCRIPTIONS OF HEALTH CARE SYSTEMS: GERMANY AND THE NETHERLANDS The German Health Care System Reinhard Busse, M.D. M.P.H. Professor of Health Care Management Berlin University of Technology & Charité
More informationConnect4 Patients CCCM Primary Care Community. Presented By: Veronica Mansfield, DNP, APRN, AE-C, CCM Kit McKinnon, MBA, BSN, RN, CDE, CCM
Connect4 Patients CCCM Primary Care Community Presented By: Veronica Mansfield, DNP, APRN, AE-C, CCM Kit McKinnon, MBA, BSN, RN, CDE, CCM September 17, 2015 Objectives: Describe innovative care management
More informationPLAN DESIGN AND BENEFITS - New York Open Access EPO 1-10/10
PLAN FEATURES Deductible (per calendar year) $1,000 Individual $3,000 Family Unless otherwise indicated, the Deductible must be met prior to benefits being payable. Member cost sharing for certain services,
More informationThe New Complex Patient. of Diabetes Clinical Programming
The New Complex Patient as Seen Through the Lens of Diabetes Clinical Programming 1 Valerie Garrett, M.D. Medical Director, Diabetes Center at Mission Health System Nov 6, 2014 Diabetes Health Burden High
More informationDrug optimisation clinics for patients with polycomorbidity: back to the future?
Drug optimisation clinics for patients with polycomorbidity: back to the future? Shakib S*, Thomas J, Maddison J, Day M, Clark R Department of Clinical Pharmacology, General Medicine and Geriatrics Royal
More informationValue and Outcome Measurement in Health Care Delivery
Value and Outcome Measurement in Health Care Delivery Grecia Hospital, Costa Rica March 2014 Profs. Elizabeth Teisberg and Scott Wallace The Geisel School of Medicine at Dartmouth Health Care s Challenges
More informationBACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
More informationNew York Small Group Indemnity Aetna Life Insurance Company Plan Effective Date: 10/01/2010. PLAN DESIGN AND BENEFITS - NY Indemnity 1-10/10*
PLAN FEATURES Deductible (per calendar year) $2,500 Individual $7,500 Family Unless otherwise indicated, the Deductible must be met prior to benefits being payable. Member cost sharing for certain services,
More informationOverview. Provider Qualifications
Overview Diabetes self management training (DSMT) is a collaborative process through which patients with diabetes gain knowledge and skills needed to modify behavior and successfully manage the disease
More informationWhat to know if Medicare denies coverage
What to know if Medicare denies coverage What Medicare covers Necessary post-hospital extended care for up to 100 days Extended care: nursing care and rehab provided to a Medicare beneficiary who is an
More informationFACTORS ASSOCIATED WITH HEALTHCARE COSTS AMONG ELDERLY PATIENTS WITH DIABETIC NEUROPATHY
FACTORS ASSOCIATED WITH HEALTHCARE COSTS AMONG ELDERLY PATIENTS WITH DIABETIC NEUROPATHY Luke Boulanger, MA, MBA 1, Yang Zhao, PhD 2, Yanjun Bao, PhD 1, Cassie Cai, MS, MSPH 1, Wenyu Ye, PhD 2, Mason W
More informationDescription of the degree programme MEDICINE. Vilnius University, Faculty of Medicine, M.K. Čiurlionio g. 21, 03101, Vilnius
Description of the degree MEDICINE Title of the degree Medicine Higher education institution(s), department(s) Vilnius University, Faculty of Medicine, M.K. Čiurlionio g. 21, 03101, Vilnius National code
More informationMedical Dental Integration Study. March 2013
Medical Dental Integration Study March 2013 Executive summary The study, which was a performed by Optum, the nation s leading health services company, on behalf of UnitedHealthcare evaluates the impact
More informationMultimorbidity in patients with type 2 diabetes mellitus in the Basque Country (Spain)
Multimorbidity in patients with type 2 diabetes mellitus in the Basque Country (Spain) Roberto Nuño-Solinís & Edurne Alonso-Morán O+berri, Basque Institute for Healthcare Innovation This presentation arises
More informationUpstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs
T H E F A C T S A B O U T Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs Upstate New York Adults with diagnosed diabetes: 2003: 295,399 2008: 377,280 diagnosed
More informationOFFICE OF GROUP BENEFITS 2014 OFFICE OF GROUP BENEFITS CDHP PLAN FOR STATE OF LOUISIANA EMPLOYEES AND RETIREES PLAN AMENDMENT
OFFICE OF GROUP BENEFITS 2014 OFFICE OF GROUP BENEFITS CDHP PLAN FOR STATE OF LOUISIANA EMPLOYEES AND RETIREES PLAN AMENDMENT This Amendment is issued by the Plan Administrator for the Plan documents listed
More informationHealth care is in a time of major transition. Eighty percent of doctors now have deployed
August 2014 The Emerging Revolution in Health Care by Darrell M. West and Niam Yaraghi Introduction Health care is in a time of major transition. Eighty percent of doctors now have deployed electronic
More informationObjectives. Clinical Impact of An Inpatient Diabetes Care Model. Impact of Diabetes on Hospitals. The Nebraska Medical Center Stats 6/5/2014
Objectives Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE Andjela Drincic, MD 1. Examine the development of the role of the diabetes case manager model in the inpatient setting
More informationThe Joint Commission Advanced DSC Certification for Inpatient Diabetes Care
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care November 12, 2013 Caroline Isbey RN, MSN, CDE Associate Director Teresa Gomez Associate Project Director Specialist-SSM Carol
More informationIntroduction: What Are Voluntary Benefits?... 3 Traditional Voluntary Benefits... 4
Table of Contents Introduction: What Are Voluntary Benefits?... 3 Traditional Voluntary Benefits... 4 Short-term Disability Insurance... 5 Long-term Disability Insurance... 7 Critical Illness Insurance...
More informationDIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa
DIABETES A chronic, debilitating and often deadly disease Diabetes is a chronic condition that arises when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin
More informationDescription of the OECD Health Care Quality Indicators as well as indicator-specific information
Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data
More informationA telemedical therapy-management-system with rule-based active patient-feedback
A telemedical therapy-management-system with rule-based active patient-feedback Austrian Research Centers GmbH ARC ehealth systems Graz - Hall in Tirol - Vienna Matthias Pinsker, Peter Kastner, Günter
More informationClinical Impact of An Inpatient Diabetes Care Model. Objectives
Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE June 4, 2014 Objectives 1. Examine the development of the role of the diabetes case manager model in the inpatient setting 2.
More informationCommunity Care Collaborative Integrated Behavioral Health Intervention for Chronic Disease Management 307459301.2.3 Pass 3
Community Care Collaborative Integrated Behavioral Health Intervention for Chronic Disease Management 307459301.2.3 Pass 3 Provider: The Community Care Collaborative (CCC) is a new multi-institution, multi-provider,
More information2012 Georgia Diabetes Burden Report: An Overview
r-,, 2012 Georgia Diabetes Burden Report: An Overview Background Diabetes and its complications are serious medical conditions disproportionately affecting vulnerable population groups including: aging
More informationFrom Concept to Rapid Visualization a Data Analytics Case Study
From Concept to Rapid Visualization a Data Analytics Case Study Gregory Wozniak, PhD Director of Outcomes Analytics Health Outcomes Group American Medical Association The Journey Objectives Share experiences
More informationTHE CHALLENGES OF FUNDING HEALTHCARE FOR AN AGEING POPULATION A COMPARISON OF ACTUARIAL METHODS AND BENEFIT DESIGNS
THE CHALLENGES OF FUNDING HEALTHCARE FOR AN AGEING POPULATION A COMPARISON OF ACTUARIAL METHODS AND BENEFIT DESIGNS 19 th November 2013 Stephen Bishop Challenges of Old Age Healthcare Provisions 1. Clinical
More informationMeasuring and Improving the Quality of Diabetes care in General Practice. Dr M Grixti. Dr C Scalpello, Dr C Mercieca, Dr P Mangion, Dr T O Sullivan
Measuring and Improving the Quality of Diabetes care in General Practice Dr M Grixti. Dr C Scalpello, Dr C Mercieca, Dr P Mangion, Dr T O Sullivan Outline of presentation Statistics Diabetes care,as the
More informationWhat you should know about Data Quality. A guide for health and social care staff
What you should know about Data Quality A guide for health and social care staff Please note the scope of this document is to provide a broad overview of data quality issues around personal health information
More informationThe Impact of the Medicare Prescription Drug Benefit on Beneficiaries with Diabetes
The Impact of the Medicare Prescription Drug Benefit on Beneficiaries with Diabetes October 2005 Prepared for: American Diabetes Association By: Avalere Health LLC Executive Summary The Medicare Part D
More informationInvestigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
More informationReview of diabetes care in London Health and Environment Committee
The London Assembly s Health and Environment Committee intends to review diabetes care in London. Aim of review The purpose of this review is for the Committee to understand the extent of diabetes prevalence
More informationBackground of the study
Assessing Adherence to the Diabetics an Oluyedun H.A (D.S.A) Background of the study Practice guidelines serve as tools for clinical decision making. They reduce practice variation, guide appropriateness,
More informationDiabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12
Diabetes Introduction The attached paper is adapted from the initial background paper on Diabetes presented to the Capital and Coast District Health Board Community and Public Health Advisory Committee
More informationPoorly controlled diabetes mellitus the way forward
Poorly controlled diabetes mellitus the way forward Presentation at HA Convention 2008 6 May, 2008 Dr. M K Cheung Associate Consultant Department of Family Medicine Community Care Division New Territories
More informationImpact Intelligence. Flexibility. Security. Ease of use. White Paper
Impact Intelligence Health care organizations continue to seek ways to improve the value they deliver to their customers and pinpoint opportunities to enhance performance. Accurately identifying trends
More informationIntegrated Physical & Behavioral Health. A Business Opportunity for Employers
Integrated Physical & Behavioral Health A Business Opportunity for Employers About the Health and Health Costs of Your Employees 80% of employees with behavioral difficulties (~20% of employer covered
More informationDiabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council
Diabetes 101 Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council www.diabetes.org 1-800-DIABETES www.diabetes.org 1-800-DIABETES Age-Adjusted
More informationDepartment of Health Public Consultation. Scope for Private Health Insurance to incorporate Additional Primary Care Service
Department of Health Public Consultation Scope for Private Health Insurance to incorporate Additional Primary Care Service Submission by Aviva Health Insurance Ireland Limited January 2015 Summary This
More informationKnowledge of diabetes mellitus amongst nursing students Effect of an intervention
Knowledge of diabetes mellitus amongst nursing students Effect of an intervention Sukhpal Kaur, Indarjit Walia Abstract : Nurses are the key providers of diabetes care. However the information provided
More informationDiabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?
Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? After eating, most food is turned into glucose, the body s main source of energy. 1 Normal Blood
More informationConcept Series Paper on Disease Management
Concept Series Paper on Disease Management Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing
More informationEnd Stage Renal Disease (ESRD)
End Stage Renal Disease (ESRD) AN OVERVIEW OF ESRD, TREATMENT COSTS & COVERAGE WSHIP Board Meeting January 14, 2015 Lisa Matthews and Sharon Becker 1 Kidney Disease Facts & Figures 1 in 10 people have
More informationDisease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification
Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare
More informationOutpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References)
CARDIAC The delivery of Cardiac Rehab is unlike most other rehab populations. The vast majority of patients receive their rehab in outpatient or community settings and only a small subset requires an inpatient
More informationInhaled Corticosteroids and Diabetes Onset
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression Journal Club October 13, 2010 By Anya Litvak, Kik Keiko Greenberg, and Jonathan Chrispin Background Inhaled corticosteroids are commonly
More informationOregon Statewide Performance Improvement Project: Diabetes Monitoring for People with Diabetes and Schizophrenia or Bipolar Disorder
Oregon Statewide Performance Improvement Project: Diabetes Monitoring for People with Diabetes and Schizophrenia or Bipolar Disorder November 14, 2013 Prepared by: Acumentra Health 1. Study Topic This
More informationMedicaid Health Plans of America Presented by Marsha Morris, Commissioner Bureau of Medical Services West Virginia Department of Health and Human
Medicaid Health Plans of America Presented by Marsha Morris, Commissioner Bureau of Medical Services West Virginia Department of Health and Human Resources November 2, 2007 Mountain Health Choices The
More informationPopulation Health Management Program
Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care
More informationAn integrated IT approach to Chronic Disease Management
An integrated IT approach to Chronic Disease Management Presented by: Steve Courtney Chief Executive Officer Health Information Systems (UK) Ltd March 2011 Who are Health Information Systems (UK) Ltd Company
More informationBrief Research Report: Fountain House and Use of Healthcare Resources
! Brief Research Report: Fountain House and Use of Healthcare Resources Zachary Grinspan, MD MS Department of Healthcare Policy and Research Weill Cornell Medical College, New York, NY June 1, 2015 Fountain
More informationMedical Plan - Healthfund
18 Medical Plan - Healthfund Oklahoma City Community College Effective Date: 07-01-2010 Aetna HealthFund Open Choice (PPO) - Oklahoma PLAN DESIGN AND BENEFITS PROVIDED BY AETNA LIFE INSURANCE COMPANY -
More informationThe Economic Benefit of Public Funding of Insulin Pumps in. New Brunswick
The Economic Benefit of Public Funding of Insulin Pumps in New Brunswick Introduction Diabetes is a chronic, often debilitating and sometimes fatal disease, in which the body either cannot produce insulin
More informationNational Diabetes Inpatient Audit
National Diabetes Inpatient Audit 2013 We are the trusted source of authoritative data and information relating to health and care. www.hscic.gov.uk enquiries@hscic.gov.uk Prepared in collaboration with:
More informationUsing Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada
Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada April 2009 Jack V. Tu, MD PhD FRCPC CANADA RESEARCH CHAIR IN HEALTH SERVICES RESEARCH Institute
More informationCollege of Physicians and Surgeons of Saskatchewan POLICY. Physician-Assisted Dying. Background. Introduction
College of Physicians and Surgeons of Saskatchewan POLICY Physician-Assisted Dying STATUS: APPROVED Approved by Council: November 2015 Amended: n/a To be reviewed: To be determined Background On February
More informationCochrane Quality and Productivity topics
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
More informationStatistics of Type 2 Diabetes
Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often
More informationAn Overview of Medicare Covered Diabetes Supplies and Services
News Flash - Understanding the Remittance Advice: A Guide for Medicare Providers, Physicians, Suppliers, and Billers serves as a resource on how to read and understand a Remittance Advice (RA). Inside
More informationSPECIALTY CASE MANAGEMENT
SPECIALTY CASE MANAGEMENT Our Specialty Case Management programs boost ROI and empower members to make informed decisions and work with their physicians to better manage their health. KEPRO is Effectively
More informationEmployee + 2 Dependents
FUND FEATURES HealthFund Amount $500 Individual $1,000 Employee + 1 Dependent $1,000 Employee + 2 Dependents $1,000 Family Amount contributed to the Fund by the employer Fund Coinsurance Percentage at
More informationMeasure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
More informationPDS Tech, Inc Proposed Effective Date: 01-01-2012 Aetna HealthFund Aetna Choice POS ll - ASC
FUND FEATURES HealthFund Amount $500 Individual $1,000 Employee + 1 Dependent $1,000 Employee + 2 Dependents $1,000 Family Amount contributed to the Fund by the employer Fund Coinsurance 100% Percentage
More informationFrequently Asked Questions
Frequently Asked Questions 1. What is the purpose of this research study?... 2 2. Who can participate?... 2 3. How is the medication given?... 2 4. Are there any other medications administered as part
More informationIndividual. Employee + 1 Family
FUND FEATURES HealthFund Amount Individual Employee + 1 Family $750 $1,125 $1,500 Amount contributed to the Fund by the employer is reflected above. Fund Amount reflected is on a per calendar year basis.
More informationFacing the challenges of CRITICAL ILLNESS
Facing the challenges of CRITICAL ILLNESS INTRODUCTION What is insurance? In life, we are all faced with threats which, if they occurred, would result in financial loss Insurance is the process of protecting
More informationDCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What
More informationBenefit Summary - A, G, C, E, Y, J and M
Benefit Summary - A, G, C, E, Y, J and M Benefit Year: Calendar Year Payment for Services Deductible Individual $600 $1,200 Family (Embedded*) $1,200 $2,400 Coinsurance (the percentage amount the Covered
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationInsulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020
Brochure More information from http://www.researchandmarkets.com/reports/2075322/ Insulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020 Description: Insulin Degludec (Type 2 Diabetes) Analysis
More informationAETNA LIFE INSURANCE COMPANY PO Box 1188, Brentwood, TN 37024 (800) 345-6022
AETNA LIFE INSURANCE COMPANY PO Box 1188, Brentwood, TN 37024 (800) 345-6022 OUTLINE OF MEDICARE SUPPLEMENT INSURANCE OUTLINE OF COVERAGE FOR POLICY FORM GR-11613-WI 01 MEDICARE SUPPLEMENT INSURANCE The
More informationThe population with diabetes is less healthy than the population without it.
Diabetes A drain on U.S. resources Some people with diabetes are able to control their condition and lead an active life. On the whole, however, people with diabetes are faced with many challenges. The
More informationMedicare Benefit Review
Medicare Benefit Review What is Medicare? Medicare is Health Insurance For people 65 or older For people under 65 with certain disabilities For people at any age with End-Stage Renal Disease (permanent
More informationIntroduction of a Standard Drug Formulary in Hospital Authority
Introduction of a Standard Drug Formulary in Hospital Authority PURPOSE This paper seeks Members views on the introduction of a Standard Hospital Authority Drug Formulary ( ) ( Standard Drug Formulary
More informationPROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS
PROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS The information listed below is Sections B of the proposed ruling
More informationInstitute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES
DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary
More informationElectronic Health Record Systems and Secondary Data Use
Electronic Health Record Systems and Secondary Data Use HCQI Expert Group Meeting 10 May 2012 Jillian Oderkirk OECD/HD Background and Needs The 2010 Health Ministerial Communiqué noted that health care
More informationWelcome to the Emory Diabetes Education Training Academy!
Welcome to the Emory Diabetes Education Training Academy! Session Title: DSME Program Overview: What a Coordinator Should Know About Reimbursement, Coding, Billing and Referrals Speakers: Amie Hardin,
More informationFlorida Alcohol and Drug Abuse Association. Presented to the Behavioral Health Quarterly Meeting Pensacola, Florida April 23, 2014
Florida Alcohol and Drug Abuse Association Presented to the Behavioral Health Quarterly Meeting Pensacola, Florida April 23, 2014 Florida Alcohol and Drug Abuse Association Founded in 1981 Currently has
More informationHow To Manage Diabetes In School
Diabetes is one of the most common chronic diseases in school-aged children, affecting about 208,000 young people in the United States. According to recent estimates, about 23,500 youths are diagnosed
More informationAgainst the Growing Burden of Disease. Kimberly Elmslie Director General, Centre for Chronic Disease Prevention
Kimberly Elmslie Director General, Centre for Chronic Disease Prevention Chronic diseases are an increasing global challenge Most significant cause of death (63%) worldwide 1 Chronic diseases cause premature
More informationThe Economic Benefit of Public Funding of Insulin Pumps in Prince Edward Island
The Economic Benefit of Public Funding of Insulin Pumps in Prince Edward Island Executive Summary Every day, Prince Edward Islanders living with type 1 diabetes take insulin to live. Many deliver insulin
More informationHumulin R (U500) insulin: Prescribing Guidance
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
More informationAbout to Retire: Preparing for Medicare Patient Financial Services Agenda Medicare Enrollment Covered Services Medicare-covered covered Preventive Services Agenda, continued Advance Beneficiary Notice
More informationMedicare Design Part A: Inpatient care, hospice, and some home health care Part B: Physician services + outpatient care Part C ( Medicare Advantage
Medicare Design Part A: Inpatient care, hospice, and some home health care Part B: Physician services + outpatient care Part C ( Medicare Advantage ): Private plan alternative to Parts A and B Part D:
More informationPeople centred research for people centred health system: translating preventive evidence into practice
People centred research for people centred health system: translating preventive evidence into practice Mark Harris, UNSW Outline Using three examples from our own work: An approach to working with practitioners
More informationNurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference?
Nurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference? More than ever before, patients receive medical care from a variety of practitioners, including physicians, physician assistants
More informationOECD Study of Electronic Health Record Systems
OECD Study of Electronic Health Record Systems Ministry of Health of the Czech Republic E health Expert Group Meeting 19 June 2012 Jillian Oderkirk OECD/HD Background and Needs The 2010 Health Ministerial
More informationShaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact
Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Task Force for the National Conference on Diabetes: The Task Force is comprised of Taking Control of
More informationDiabetes and kidney disease. The foundation of kidney care.
Diabetes and kidney disease The foundation of kidney care. T H E K I D N E Y F O U N D A T I O N O F C A N A D A 1 Diabetes and kidney disease What is diabetes? Diabetes is a disease that is caused by
More informationI. Insurance Reforms and Expansion of Coverage. Implementation Date Plan years beginning on or after six months after passage of the Act.
University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) Summary of Selected Tobacco, Prevention, and Public Health Provisions from H.R. 3590, the Patient Protection and Affordable
More informationPhysiotherapy-Based Rehabilitation after Total Hip or Knee Arthroplasty. CURRENT AUSTRALIAN PRACTICE Hart AJ, Chua MJ, Naylor JM, Mittal R, Harris IA
Physiotherapy-Based Rehabilitation after Total Hip or Knee Arthroplasty CURRENT AUSTRALIAN PRACTICE Hart AJ, Chua MJ, Naylor JM, Mittal R, Harris IA Acknowledgements and Funding Funding: HCF Research Foundation
More informationSHORT CLINICAL GUIDELINE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SHORT CLINICAL GUIDELINE SCOPE 1 Guideline title Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 1.1 Short title Type 2
More informationOverarching Goals. Short-term Action Steps (2 4 weeks after the Accelerated Development Learning Session)
Implementation Planning Guide 3 Overarching Goals Use this worksheet to document your ACO's overarching goals related to the three-part aims: Improve quality of care for individuals; improve health of
More informationChander Sehgal, MD, MBA Director, Common Drug Review (CDR) Taipei, Taiwan July 23 26, 2012
Chander Sehgal, MD, MBA Director, Common Drug Review (CDR) Taipei, Taiwan July 23 26, 2012 CANADIAN PERSPECTIVE Common Drug review: A *pan-canadian process CANADA: 33 M people; area 10 M km 2 DIVERSITY!
More information